Yep, therefore making it even more beneficial as an early introductory drug for early onset parkinson which may also be MSA which is undefined in the early stages, all pluses.
How did you find the webinar Iron ?.
He did also mention another area/enzyme they are focusing on, but its slipped my mind and I want to look further into it.
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial, page-137
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(12.5%) |
Mkt cap ! $18.62M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $18.65K | 5.305M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 50 | 57052005 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 125915200 | 27 |
View Market Depth
| Last trade - 14.28pm 29/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |